ABOUT RENTSCHLER BIOPHARMA

Rentschler Biopharma - Your partner for high-quality biopharmaceuticals

At Rentschler Biopharma, we enable your product’s success by translating medical research into outstanding biopharmaceuticals. We live your product - from concept to market.
 
Founded in 1927, we are a family-owned company with almost 50 years of proven scientific expertise in biotechnology. We are a leading global contract development and manufacturing organization (CDMO) offering bioprocess development and cGMP manufacturing for high-quality biopharmaceuticals. From our headquarters in Laupheim, Germany, and our site in Milford, MA, USA, we provide the best solutions to meet your clinical and commercial needs. In Stevenage, UK, we launched a company dedicated to cell and gene therapies, Rentschler ATMP Ltd.

Our strength lies in our experience with highly complex molecules. Fusion proteins, recombinant enzymes, monoclonal and multi-specific antibodies, are among the 100 different formats that we have handled. Our track record of 300 molecules for 150 clients worldwide, translates to unrivalled experience along the entire biopharmaceutical value chain.
 
Our attention is firmly focused on your needs. We guarantee best-fit solutions for your product by balancing timeline requirements with a comprehensive manufacturability assessment, and always putting quality first. This commitment is reflected in our outstanding regulatory track record, as well as our exceptional client-oriented project management and regulatory support.

In order to offer value-adding solutions across the entire process chain and helping to efficiently address the challenges of increasingly complex biopharmaceuticals, we have entered into a strategic alliance with Leukocare AG for formulation development.

Rentschler Biopharma is more than just a CDMO, we are a valuable strategic partner to grow with. We shift boundaries - Together with you.